{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T04:40:45Z","timestamp":1765082445261,"version":"3.46.0"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["NHLHCRF-LX-02-0105"],"award-info":[{"award-number":["NHLHCRF-LX-02-0105"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,1,4]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a progressive inflammatory autoimmune disease characterised by chronic systemic inflammation, which can cause swelling, stiffening and destruction of articular cartilage and bone. Early diagnosis and treatment of RA can improve outcomes and slow the progression of joint damage. Preliminary exploratory research had hinted an expected effect of modified Zhiwang decoction (MZWD) in treating early RA. However, few randomised clinical trials have evaluated the effectiveness of MZWD in early RA. Therefore, a parallel-group randomised controlled trial was designed to evaluate the efficacy and safety of MZWD combined with methotrexate (MTX) on early RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a prospective, parallel-group, single-centre randomised controlled clinical study. A total of 150 patients will be randomly assigned to either the treatment (n=75) or control group (n=75). The treatment group will receive MZWD and MTX, and the control group will receive MTX for 12 weeks. The primary outcome of this study is Disease Activity Score-28, and the secondary outcomes are Fatigue Scale-14, Visual Analogue Scale pain scores and traditional Chinese medicine symptom scores. Safety outcomes, including adverse events and results of ECG and laboratory tests, will be monitored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval was obtained from the Clinical Research Ethics Committee of the China-Japan Friendship Hospital (no. 2022-KY-124) on 8 July 2022. The findings will be disseminated in peer-reviewed publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05508815\">NCT05508815<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-076571","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T22:15:14Z","timestamp":1705616114000},"page":"e076571","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of the modified Zhiwang decoction combined with methotrexate in early rheumatoid arthritis: study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct05508815","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Nan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of TCM Rheumatism, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu-bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-480X","authenticated-orcid":false,"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-yi","family":"Lan","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of TCM Rheumatism, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Xiao","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Wen","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of TCM Rheumatism, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3189-4775","authenticated-orcid":false,"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of TCM Rheumatism, China-Japan Friendship Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"2025120619052194000_14.1.e076571.1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.berh.2018.10.005","article-title":"Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis","volume":"32","author":"van der Woude","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025120619052194000_14.1.e076571.2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025120619052194000_14.1.e076571.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"2025120619052194000_14.1.e076571.4","first-page":"1135","article-title":"Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need","volume":"57","author":"de Hair","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025120619052194000_14.1.e076571.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31491-5"},{"key":"2025120619052194000_14.1.e076571.6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1586\/1744666X.2014.917963","article-title":"Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis","volume":"10","author":"Moudgil","year":"2014","journal-title":"Expert Review of Clinical Immunology"},{"key":"2025120619052194000_14.1.e076571.7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1089\/acm.2017.0098","article-title":"Efficacy and safety of Guizhi-Shaoyao-Zhimu decoction for treating rheumatoid arthritis: a systematic review and meta-analysis of randomized clinical trials","volume":"23","author":"Daily","year":"2017","journal-title":"J Altern Complement Med"},{"key":"2025120619052194000_14.1.e076571.8","first-page":"1298","article-title":"Clinical observation on 30 cases of rheumatoid arthritis treated with Bushen Quhan Zhiwang decoction combined with methotrexate","volume":"27","author":"Wang","year":"2021","journal-title":"J Basic Chin Med"},{"key":"2025120619052194000_14.1.e076571.9","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.4639"},{"key":"2025120619052194000_14.1.e076571.10","first-page":"21","article-title":"Effects of Spatholobi Caulis MeOH extract on the production of NO and pro-inflammatory cytokines in LPS-activated Raw264. 7 cells","volume":"24","author":"Choe","year":"2009","journal-title":"Korean J Herbology"},{"key":"2025120619052194000_14.1.e076571.11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/13880209.2020.1810287","article-title":"Anti-proliferation and anti-migration effects of an aqueous extract of Cinnamomi Ramulus on Mh7A rheumatoid arthritis-derived fibroblast-like Synoviocytes through induction of apoptosis, cell arrest and suppression of matrix metalloproteinase","volume":"58","author":"Liu","year":"2020","journal-title":"Pharm Biol"},{"key":"2025120619052194000_14.1.e076571.12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/PPA.S145221","article-title":"A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against Dmards versus conventional therapy including Dmards for patients without preference","volume":"12","author":"Hamre","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"2025120619052194000_14.1.e076571.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"2025120619052194000_14.1.e076571.14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid arthritis: advances in treatment strategies","volume":"478","author":"Prasad","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"2025120619052194000_14.1.e076571.15","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(93)90081-P"},{"key":"2025120619052194000_14.1.e076571.16","unstructured":"Zheng Y . Guiding Principles for Clinical Research of New Chinese Medicine (trial) (M). Beijing: China Pharmaceutical Science and Technology Press, 2002."},{"key":"2025120619052194000_14.1.e076571.17","first-page":"1401","article-title":"Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the rheumatology common toxicity criteria V.2.0","volume":"34","author":"Woodworth","year":"2007","journal-title":"J Rheumatol"},{"key":"2025120619052194000_14.1.e076571.18","first-page":"67","article-title":"The evaluation of clinical efficacy and safety of Bushenqinghuazhiwang decoction combined with methotrexate in the treatment of rheumatoid arthritis belonging to dampness-heat injury kidney syndrome","volume":"32","author":"Wang","year":"2018","journal-title":"J China Jpn Friendship Hosp"},{"key":"2025120619052194000_14.1.e076571.19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"2025120619052194000_14.1.e076571.20","first-page":"345","article-title":"Practical tips for surgical research: blinding: who, what, when, Why, how?","volume":"53","author":"Karanicolas","year":"2010","journal-title":"Can J Surg"},{"key":"2025120619052194000_14.1.e076571.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7259.504"},{"key":"2025120619052194000_14.1.e076571.22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ptr.2084","article-title":"The design and evaluation of placebo material for crude herbals: artemisia Afra herb as a model","volume":"21","author":"Dube","year":"2007","journal-title":"Phytother Res"},{"key":"2025120619052194000_14.1.e076571.23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.joim.2022.02.005","article-title":"Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine","volume":"20","author":"Guo","year":"2022","journal-title":"J Integr Med"},{"key":"2025120619052194000_14.1.e076571.24","unstructured":"Huang Q , Xiao J , Sun Y , et al . Preparation method and quality evaluation of traditional Chinese medicine compound placebo. J Tradit Chin Med 2015:1294\u20137. doi:10.13288\/j.11-2166\/r.2015.15.010"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-076571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:05:34Z","timestamp":1765076734000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-076571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,18]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/bmjopen-2023-076571"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-076571","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}